[1] Bortnick AE, Bartz TM, Ix JH, et al. Association of inflammatory, lipid and mineral markers with cardiac calcification in older adults[J]. Heart, 2016. [2] Lehmann N, Erbel RA, Mahabadi AA, et al. Value of Progression of Coronary Artery Calcification for Risk Prediction of Coronary and Cardiovascular Events: Result of the Heinz Nixdorf Recall (HNR) Study[J]. Circulation, 2017. [3] 中华医学会心血管病学分会介入心脏病学组, 中国医师协会心血管内科医师分会血栓防治专业委员会, 中华心血管病杂志编辑委员会. 中国经皮冠状动脉介入治疗指南(2016)[J]. 中华心血管病杂志, 2016,(5): 382-400. [4] Levine GN, Bates ER, Blankenship JC, et al. 2015 ACC/AHA/SCAI Focused Update on Primary Percutaneous Coronary Intervention for Patients With ST-Elevation Myocardial Infarction: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention and the 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction[J]. J Am Coll Cardiol, 2016,67(10): 1235-1250. [5] Korkmaz L, Pelit E, Bektas H, et al. Aortic valve sclerosis in acute coronary syndrome patients : potential value in predicting coronary artery lesion complexity[J]. Herz, 2014,39(8): 1001-1004. [6] Sannino A, Losi MA, Giugliano G, et al. Aortic and Mitral Calcification Is Marker of Significant Carotid and Limb Atherosclerosis in Patients with First Acute Coronary Syndrome[J]. Echocardiography, 2015,32(12): 1771-1777. [7] Adler Y, Vaturi M, Fink N, et al. Association between mitral annulus calcification and aortic atheroma: a prospective transesophageal echocardiographic study[J]. Atherosclerosis, 2000,152(2): 451-456. [8] Adler Y, Herz I, Vaturi M, et al. Mitral annular calcium detected by transthoracic echocardiography is a marker for high prevalence and severity of coronary artery disease in patients undergoing coronary angiography[J]. Am J Cardiol, 1998,82(10): 1183-1186. [9] Aladin AI, Al Rifai M, Rasool SH, et al. Relation of Coronary Artery Calcium and Extra-Coronary Aortic Calcium to Incident Hypertension (from the Multi-Ethnic Study of Atherosclerosis)[J]. Am J Cardiol, 2018,121(2): 210-216. [10] 刘宇, 陈曼君, 李晨, et al. 心踝血管指数与冠心病左主干病变患者危险程度相关性研究[J]. 中国医药导刊, 2016,(3): 217-218. [11] Testuz A, Nguyen V, Mathieu T, et al. Influence of metabolic syndrome and diabetes on progression of calcific aortic valve stenosis[J]. Int J Cardiol, 2017,244: 248-253. [12] 周秀芳, 杨彩哲. 糖尿病足合并冠心病的危险因素分析[J]. 中国医药导刊, 2017,(2): 130-132. [13] Tsimikas S, Duff GW, Berger PB, et al. Pro-inflammatory interleukin-1 genotypes potentiate the risk of coronary artery disease and cardiovascular events mediated by oxidized phospholipids and lipoprotein(a)[J]. J Am Coll Cardiol, 2014,63(17): 1724-1734. [14] Badimon L, Badimon JJ, Penny W, et al. Endothelium and atherosclerosis[J]. J Hypertens Suppl, 1992,10(2): S43-50. [15] Shioi A, Ikari Y. Plaque Calcification During Atherosclerosis Progression and Regression[J]. J Atheroscler Thromb, 2017. [16] Okada H, Tada H, Hayashi K, et al. Aortic Root Calcification Score as an Independent Factor for Predicting Major Adverse Cardiac Events in Familial Hypercholesterolemia[J]. J Atheroscler Thromb, 2018. [17] Caffarelli C, Montagnani A, Nuti R, et al. Bisphosphonates, atherosclerosis and vascular calcification: update and systematic review of clinical studies[J]. Clin Interv Aging, 2017,12: 1819-1828. [18] 林艾雯, 陈竹君. 动脉粥样硬化与内皮细胞损伤机制的研究进展[J]. 岭南心血管病杂志, 2015,(4): 580-582. [19] Gaibazzi N, Porter TR, Agricola E, et al. Prognostic value of echocardiographic calcium score in patients with a clinical indication for stress echocardiography[J]. JACC Cardiovasc Imaging, 2015,8(4): 389-396. [20] 严泽振. 血管钙化中成骨样细胞来源及其转化的研究进展[J]. 中国动脉硬化杂志, 2017,(11): 1169-1173.
|